Éèç€ã®ããã®35幎åŸã®çµå£é¿åŠè¬
äžçã®å»çé¢ä¿è ããå©çšè ããæããã匟æ§ã¹ãããã³ã°ããããµã³ãã劥åãèš±ããªãå質ãšã飜ããªãé©æ°ãžã®æ ç±ã§ãããŸãªããã®ãäžçæé«æ°Žæºãã®æŽå²ã¯ç¶ããŠããŸãã.1966幎5æ. è¬å¹åé¡å. äžè¢éèç€ç¡¬åå€ çµå£é¿åŠè¬ãæçšããŠããæ£è ã æäžéšäœã®å§è¿«ã¯ãå³æå§è¿«ãé¿ãã倧äŒåšéèåã³å°äŒåšéèã®æ²»çã«ãããŠã¯çŽ10ååŸãåŽæéèç€ãåçºéèç€åã¯ç©¿éæéèã®æ²»çã«ãããŠã¯çŽ5ååŸã«æåçã§å§è¿«åŸ.ocïŒäœçšéçµå£é¿åŠè¬ïŒãocïŒäœçšéçµå£é¿åŠè¬ïŒã®æŠèŠãæçšæ¹æ³ãã³ã³ããŒã ã®äœ¿çšæ¹æ³ãªã©ããŸããŸãªé¿åŠæ³ã«é¢ãã詳ããæ å ±ãåããããã玹ä»ããŸããè¿ãã®å©Šäººç§ã»ç£å©Šäººç§ã®ç é¢ãæ€çŽ¢ããã®ã«ã䟿å©ã§ãã äœçšéçµå£é¿åŠè¬ïŒãã«.P2-46-7 çµå£é¿åŠè¬ã»ãã«ã¢ã³è£å çæ³ãå®å šã«æäžããããã« : ãããã€ã³S掻æ§æž¬å®ã®éèŠæ§ã«ã€ããŠ(Group 87 LEP/OC,äžè¬æŒé¡,å ¬ç瀟å£æ³äººæ¥æ¬ç£ç§å©Šäººç§åŠäŒç¬¬67ååŠè¡è¬æŒäŒ).æåéãéèå ã«è¡æ ãçããç æ ã§ãã, äž»ã«æ·±éšéèè¡æ ç(DVT)ãèºå¡æ ç(PE)ã®ããšã瀺ã. 第äºäžä»£çµå£é¿åŠè¬*(norgestrel, levonorgestrel),第äžäžä»£çµå£é¿åŠè¬**(desogestrel, gestodene, æè¡æ²»çåŸæ©æã§ã¯VTEãªã¹ã¯ã¯åœç¶é«ãã, å幎ã1幎çµéããŠããªã¹ã¯.éèç€ã®äžã«ç¡¬åå€ãšãããè¬ãæ³šå ¥ããŠãå€ããå§è¿«ãããããšã§éèãéå¡ãããŸãã å€æ¥ã§æ²»çãå¯èœã§ããæ²»çã¯15åãã30åçšåºŠã§çµãããŸãããéèç€ãåºç¯å²ã«ãããå Žåã¯è€æ°åã«åããŠè¡ãããšããããŸãã.ç¹ã«çã¿ãããããã§ã¯ãªãã®ã«ãè¬å±ã§ããã¡ãªã³ãåãåããŸããããªãïŒããã¯ãè¡æ¶²ãåºãŸãã®ãé²ãããã§ããä»åã¯ãã¢ã¹ããªã³ã®æåè¡äœçšã«ã€ããŠã玹ä»ããŸãã(2ããŒãžç®).æ¿èªå¹Žææ¥: å¹³æ22 幎6 æ14 æ¥ (å¹³æ23 幎1 æ1 æ¥ä¿éºé©çšéå§) 䜿çšç®ç äžæ¬¡æ§äžè¢éèç€ïŒè¡ç®¡åŸ20mm 以äžã®å€§äŒåšéèç€ â§çµå£é¿åŠè¬åã¯ãã«ã¢ã³å€ãæçšããŠããæ£è ã âšæœè¡è¢ã«åéèç»ã®ããå Žåã.çµå£é¿åŠè¬ããšã¹ããã²ã³çæ³è¬ããšã¹ããã²ã³ãšäŒŒãäœçšããã€è¬ïŒã¿ã¢ãã·ãã§ã³ãã©ããã·ãã§ã³ïŒãªã©ãäžéšã®è¬å€ã¯è¡æ¶²ååºãä¿é²ããå¯èœæ§ããããŸããå«ç ãå±éºå åã§ããåºç£åŸãæè¡åŸã«ãè¡æ ãã§ããããããšããããŸãã.
æããããå»çããã
粟玢éèç€ã¯ã粟巣æ©èœã«åœ±é¿ãäžãã粟åãé ãæ©èœãäœäžãããã粟åã®dnaã®æå·ãæããç·æ§ãã«ã¢ã³ã®äœäžãåŒãèµ·ãããŸãããä¹ç²Ÿåçã»ç²Ÿåéåçäœäžãã®35ïŒ ã®æ¹ã粟玢éèç€ãåå ã§ã2人ç®äžåŠã®78ïŒ ã®åå ã粟玢éèç€ãšèšãããŠããŸãã.è¬æŒäŒ 2002幎3æ24æ¥ã«å€§éªã§éå¬ããããããããç ã®æ£è ãšå®¶æã®äŒãã®å¹Žæ¬¡ç·äŒã§ããããããç ãšåŠåš ã»åºç£ããã³ãã®ä»ã®ç æ°ããšããã¿ã€ãã«ã§ãè¬æŒããããŠããã ããŸããïŒå 容ã¯ãåºæ¬çã«ã¯ããŒã ããŒãžäžã«ããæ å ±ãäž»äœã§ã話ãããŸããïŒ.ïŒè¡æ çïŒ 5 éèè¡æ çã®æ¢åŸ 5 ã¢ãã ãã«ããè¡æ çã®éºäŒççŽ å ïŒå®¶ææŽ 5 æãªã³è質æäœçå矀 3 äžè¢éèç€ 2â5 çµå£é¿åŠè¬ïŒãšã¹ããã²ã³è£œå€ ïŒå æäžïŒ5ç¹ïŒ1ãæ以äžã®äŒè¬åŸïŒ2ç¹ïŒ ïŒå䜵çïŒ 2 èªå·±å ç«çŸæ£ 2 ç³å°¿ç 1 äžæŽèïŒå¿æ¿çŽ°åãªã©ïŒ.1ïŒå€åœã®ç«åŠèª¿æ»ã®çµæãéèè¡æ çã®ãªã¹ã¯ã¯ãçµå£é¿åŠè¬ãæçšããŠãã女æ§ã¯æçšããŠããªã女æ§ã«æ¯ãã3.25ã4.0åé«ããªããšã®å ±åã.çµå£é¿åŠè¬ ã®æ害äºè±¡ãšãã®å¯Ÿç 確å®ãªé¿åŠæ¹æ³ãæ±ããŠæ¥é¢ãããæè¿2幎ã®éã«ãæãŸãªãåŠåš ã®ãã2å人工åŠåš äžçµ¶æè¡ãåãããå°æ¥ã®æå åžæã¯ãªãã äžè¢éèç€.äœçšéãã«ã»é¿åŠãã« ã¯ã©ã€ãªã¹ã¿(Qlairista) çæ®åšãååšå®ããåæ³ããããšã¹ããã²ã³ã®äžã§ãæãå«ææ¯çã®é«ãæåã®ã²ãšã€ã§ãã§ããããšã¹ã©ãžãªãŒã«ãäž»æåãšããçµå£é¿åŠè¬ã§ããBayerïŒãã€ãšã«ïŒç€Ÿã®ã¯ã©ã€ãªã¹ã¿ã¯ãçµå£é¿åŠè¬ã§ããè¬å¹æåã®ãšã¹ãã©ãžãªãŒã«åèé ž.2013幎8æ25æ¥ çµå£é¿åŠè¬ - å»åž«ã«çžè«ããããšãå¿ããªãã§ãã ãã ããŒã«ã«ã«äœ¿çšããããã®çµåããã«ã¢ã³é¿åŠè¬ãããã«ããŸãã¯éãã«ã¢ã³ã®é å€ïŒè¬ã®äœçšæ©åºã¯ã圌ããæå±ããã°ã«ãŒãã«äŸåããŸãã è€åçµå£é¿åŠè¬ è€åçµå£é¿åŠè¬ã¯.[mixi] ãã¡ããšç¥ããå¥åº·çŸâª ãã³ã°ãã©ã€ãè¡æ çïŒãšã³ãããŒã¯ã©ã¹çåçŸ€ïŒ ht æ·±éšéèè¡æ çïŒDVTïŒãšã³ãããŒã¯ã©ã¹çåçŸ€ïŒ ãã³ã°ãã©ã€ãè¡æ ç(LFT)ã£ãŠã©ããªç æ°ïŒ âââââââââ 6æé以äžã®ãã©ã€ãæã«ãéåãšè ¹å§ã«éãã£ãŠãå¿èã«è¡æ¶²ãéãè¿ããªããã°ãªããªã.ãŸããé·æïŒæ°ã¶æïœ20 æ°å¹ŽïŒã®æçšåŸã«èã®éå±æ§çµç¯æ§é圢æ(focal nodularhyperplasia [FNH])ãè ºè «ãèçãçºçããããšãããããŸãããšã¹ããã²ã³ã¯èç±æ¥ã®ååºå åãå¢å ãããããèéèè¡æ çãæ¹èµ·ããããšãããã.
Related queries:-> éèç€ç¡¬åçæ³ã®æ²»çã¯çããã®ã«æé©ã§ãã
çµå£é¿åŠè¬ãæçšããŠããæ£è ã æäžéšäœã®å§è¿«ã¯ãå³æå§è¿«ãé¿ãã倧äŒåšéèåã³å°äŒåšéèã®æ²»çã«ãããŠã¯çŽ10ååŸãåŽæéèç€ãåçºéèç€åã¯ç©¿éæéèã®æ²»çã«ãããŠã¯çŽ5ååŸã«æåçã§å§è¿«åŸã匟åå 垯åã¯åŒŸåã¹ãããã³ã°ãè£ çã.Por ejemplo, å»ççžè«ãããé »ç¹ã«åºåžãããããããå€ãã®è «çã¯é¿åŠè¬ã䜿çšããŠå¥³æ§ã«æ€åºãããããšãã§ãã. åšæ³¢æ°ã®å¢å ã¯åŸã ã«æ²»çãåæ¢ããåŸæžå°. 10幎åŸ, ä¹³çã®å¯èœæ§ã¯çµå£é¿åŠè¬ã䜿çšããããšããªã女æ§ã®å Žåãšåãã§ã.83ãçµå£é¿åŠè¬ïŒäœçšéãã«ïŒãå䜵çãçœå éãé«çŒå§çã網èéèéå¡çã滲åºæ§ç¶²èå¥é¢ãããªãŒãç¶è絡èè¡ç®¡ç 84ãæ» èæ¹æ³ãããªããã«ã¢ã«ã³ãŒã«ãšãŠçŽ ãã¯ãã«ããã·ãžã³ã°ã«ã³ã³é žå¡©ããã³ã¶ã«ã³ããŠã å¡©åç©ãã»ãã«ãªã³é ž.çµå£é¿åŠè¬(ãã«)ã®çš®é¡ã«ã€ããŠè³ªåã§ãã çŸåšãçµå£é¿åŠè¬(ãã«)ãæçšããŠããã®ã§ãããããªãã¥ã©ãŒ28ããã£ãšé£²ãã§ããŠãä»å¹Žã«å ¥ãããŒããã³28ãåºãããŸãããã§ãããããŒããã³ã¯ãã«ã¢ã³ãäžå®ã ãšèããŠäœã«å¯Ÿã.è¥å¹Žå¥³æ§ã®åéèè¡æ çã®åå ã«çµå£é¿åŠè¬ãé¢ä¿ããŠããå¯èœæ§ãããã çµå£é¿åŠè¬ã®ã»ãšãã©ã¯ç£å©Šäººç§éæ¥å»ã§åŠæ¹ãããŠããã äžæ¹ã§ãä»åã®5çäŸã®ããã«èº«äœçç¶ã䞻蚎ã«ç£å©Šäººç§ä»¥å€ã®ç§ãå蚺ããŠã ãããšãå€ããšæšæž¬ãããã.ãŠãã.è¡æ çã¯éèè¡æ ã»å¡æ çãšåèè¡æ çãšã«åããããšãã§ãã.åè ã¯æ·±éšé å¿è¡ç®¡ç³»çŸæ£ã®ãªã¹ã¯ã®ãããã«æçšãçŠå¿ãšãªãå Žåãè¡š5ã«,æ éãªå€æã®ããš.ãã«ãšã¯ æ¥æ¬ã§ã®é¿åŠçšå¥³æ§ãã«ã¢ã³å€ãæãä¿ç§°ã§ãçµå£é¿åŠè¬ïŒOC: oral contraceptiveïŒãšãåŒã°ããŸãã æ¯æ¥åãæå»ã«é£²ã¿å¿ããªãæçšããããšã§è¡æ¶²äžã®ãã«ã¢ã³æ¿åºŠãäžå®ããåµå·£ãåããªããŠãããç¶æ ã«ãªãæåµãèµ·ãããªããªããŸãã æåµãåæ¢ãããããšã«ãããã¡ãããš.éè路確ä¿åŸã«è¡ã£ãç·æ¥äžéšæ¶å管å èŠé¡æ€æ»ã®é£éåçãå¥ã«ç€ºãã ïŒé£éåçã§ã¯ãé£éäžéšãé£éèæ¥åéšãã6ææ¹åãžæ¡åŒµãèè¡ããéèãèªããã ãã®éèããåŽåºæ§åºè¡ãåããŠãããéèã¯ç€ç¶ã§ã¯ãªããè²èª¿ãçœè²ã§ããïŒ.æº,åŠ åš ,çµ å£é¿åŠè¬ã®æçš,è¡ æ æ§éèçã®æ¢åŸãª ã©ããã.ç äŸ1㧠ã¯,çµ å£é¿åŠè¬ã®æçš,ç äŸ2㧠ã¯è¥æºããã£ã.ä» åŸçµå£é¿åŠè¬ã®è§£çŠããªããã°, èºæ å¡ã®çºççãå¢å ãããšèãããã.ã ãäžå±€ã® 泚æãåèµ·ããã.
-> éèç€ã®æ²»çã®ããã®å¹æçãªæ²»çæ³ïŒè»èãã²ã«ãé å€ïŒ
15幎7æããæ¬ççºçäºé²ããã¥ã¢ã«ãäœæã åšè¡æã®èºè¡æ å¡æ çã®äºé²ãå®è·µããŠããã ãã®å¹æãšææã«ã€ããŠå ±åããã 察象ãšæ¹æ³ å¹³æ15幎7æããå¹³æ16幎8æã«é·éç·åç é¢å€ç§ã§æè¡ãã19æ³ãã93æ³ã®å šèº«éº»é æè¡.ïŒå€åœã§ã®å€§èŠæš¡åžè²©åŸèª¿æ»ã«ããã2幎以äžã®è¿œè·¡èª¿æ»ã®çµæïŒæ¬å€ã®éèè¡æ çã®çºçŸçã¯10,000婊人幎åœãã7.2件ã§ããïŒéèè¡æ çã®ãªã¹ã¯ã¯é¡è¬ïŒã¬ããã«ã²ã¹ãã¬ã«çãå«æããçµå£é¿åŠå€ïŒãšåçã§ããããšãå ±åãããŠããïŒãªãïŒå€åœã§ã®.çŽè žéèç€ã®è¡è¡åæ ããã³ãã®æ²»çæŠç¥ ç°ç æä¹ 1ïŒæ æèïŒä»æ 最1ïŒæšæ å ¬å1ïŒäœäŒ¯ ä¿äž1 åœç§ã§æ²»çãæœè¡ããçŽè žéèç€19 äŸã察象ã«ïŒçŽè žéèç€ã®è¡è¡åæ ããã³ãã®æ²»çæŠç¥ã«ã€ã.å æ¥å€«ãé£ééèç€ç Žè£ã§åè¡ãææ¥è»ã§éã°ãå ¥é¢ãããŸãããç åã¯é£ééèç€ç Žè£ãã¢ã«ã³ãŒã«æ§èçã§1é±é匱ã§éé¢ããŸãããä»ã¯èªå® çé€äžã§çŠé ãããŠããŸããæ²»ãã®ã§ããããã éé¢åŸã¯èªå® çé€ã§éé¢ã«ãŠæ²»çã.åèç€ãšéèç€ã®äœã«åªããæ²»çæ³ ïŒã¹ããã€ãã»ãã«ã¢ã³æ²»çã»çµå£é¿åŠè¬ã»éªšç²ãããçæ²»çè¬ å¿èãšèºã®æ©èœ.éèç€çŸæ£ã¯ä¿éºã«å å ¥ãããŠããŸãããªããã女æ§ã倪ãããã®çµå£é¿åŠè¬ãåŠåš ã¯ã座ã£ããã®è¡ã«é·ãæéæŸçœ®ããå¿ èŠãããã窮å±ãªãäžå¿«ãªéŽã¯ - ãã®ãã¹ãŠãåé¡ãåŒãèµ·ããå¯èœæ§ããããŸãã.çµå£é¿åŠè¬ãæçšããŠããæ£è ã äŒåšéèç€æ¬å¹¹ã®æ²»çãè¡ãå Žåã«ã¯ãããªãã«ã¹ã¯ã¬ããŒã«1ïŒ æ³š2mLåã¯ããªãã«ã¹ã¯ã¬ããŒã«3ïŒ æ³š2mLãçšããŠããã©ãŒã 硬åçæ³ åçŸæ£ããããããé害ãèµ·ããæãã 0.5ïŒ , 1mmæªæº, 37äŸ, 35/37ïŒ94.6ïŒ ïŒ.é«è¡å§æ²»çè¬ïŒãããã€ãã€ã¡ããããããè±: Anti-hypertensive ïŒã¯ãå»è¬åã®åé¡ã®äžã€ã§ãããäœããã®åå ã§è¡å§ãæ£åžžç¯å²ããæç¶çã«éžè±ããŠããå ŽåïŒããããé«è¡å§ïŒãå ·äœçã«ã¯åçž®æè¡å§ïŒæé«ïŒã140mmHg以äžãããã¯æ¡åŒµæè¡å§ïŒæäœïŒã90mmHg以äžã®å Žåã«ããã®è¡å§ãäœäžã.ãã®æªåŸªç°ãæã€ããã«ã¯ãçžè«çªå£ã®å å®ãæå¹ã§ãã欧米ã§ã¯å°åã«é¿åŠçžè«çªå£ããããŸããæ¥æ¬ã§ã¯ãOCæ å ±ã»ã³ã¿ãŒããã®åœ¹å²ãæããããšã«ãªã£ãŠããŸãããŠãŒã¶ãŒçžè«æ¥åã¯2000幎9æãçµäºããŠããŸããŸããã [æ±äº¬]03-3814-1809.
-> éèç€ã®é€å»ã®ããã®æè¡äŸ¡æ Œããšã
éèè¡ã®é¬±åž¯ïŒãã£ããïŒãè¡æ¶²ååºã®äº¢é²ãæ倧ã®åå ãšãªããè¡æµãã£æ»ïŒè¡æ¶²ã®æµããæ»ãããšïŒã®åå ãšããŠã¯é·æéåã姿å¢ã§å± ç¶ããããšããã£è¡ïŒãã£ãã€ïŒæ§å¿äžå šãäžè¢éèç€ã®ååšãæããããã.äžèšã®å 倩æ§ããã³åŸå€©æ§è¡æ æ§çŽ å ä¿æè ã«ã¯è©²åœããªãããå«ç ã軜床ã®è¥æºãéèç€ãè¡æ¶²çæ€æ»ãªã©ã§è¡æ çã®ãªã¹ã¯ãæãããšå€æãããå Žåã«ã¯ãæ éã«æäžãæ€èšããè¡æ¶²ååºç³»æ€æ»ãè¡ããæ€æ»å€ã«ç°åžžãããå Žåã«ã¯æäžããªãã.ç·æ¥é¿åŠè¬ - å¯äœçšãäžè¬çã§ã 2012幎12æ12æ¥ ãã®ãããªç·æ¥é¿åŠè¬ãçšã§ããå Žåã«ã¯ãäžå®æéåŸã«éåžžæ£åžžãªæçµåšæã§ãã ããããé »ç¹ã«äœ¿çšããã«ã¯ãé·æã®æçµé害ã¯ãäžåŠã¯è€éãããããŸããã.æ¹ã§æ©æ¢°çç Žæã«ããè¡å°æ¿ã®æ¶èãå¿ çºãããããåºè¡ããã»ãš ãã©ã®å Žåã§èŒžè¡ãå¿ èŠã«ãªãã èªèãããå Žåã«ã¯ãå³å¿ç³»ã®åè² è·ã¯æžãããã倧åèãžã®é è¡ã§å·Šå®€åŸè² è·ãå¢å ãããããããã£ãŠå¿æ©èœãæªåãããèºæ°Ž è «ããããããšãããã.å€åœã§ã®å€§èŠæš¡åžè²©åŸèª¿æ»ã«ããã2幎以äžã®è¿œè·¡èª¿æ»ã®çµæïŒæ¬å€ã®éèè¡æ çã®çºçŸçã¯10,000婊人幎åœãã7.2件ã§ããïŒéèè¡æ çã®ãªã¹ã¯ã¯é¡è¬ïŒã¬ããã«ã²ã¹ãã¬ã«çãå«æããçµå£é¿åŠå€ïŒãšåçã§ããããšãå ±åãããŠããïŒãªãïŒå€åœã§ã®å°æ°.ãã®ãããaã¡ãããšæ¯èŠªã«ãéé¢åŸãæã¢ã¬ã«ã®ãŒè¬ã®å æãšå¯è ç®è³ªã¹ããã€ãè¬ã®åžå ¥ãç¶ããããã«å»åž«ãã説æãããã çè·åž«ã®aã¡ããã«å¯Ÿããéé¢åŸã®æå°ã§é©åãªã®ã¯ã©ããã 1. å³ãåºãªããŠãäœè²ã®ææ¥ã¯èŠåŠããŸããã.å€åœã®ç«åŠèª¿æ»ã®çµæãéèè¡æ çã®ãªã¹ã¯ã¯ãçµå£é¿åŠè¬ãæçšããŠãã女æ§ã¯æçšããŠããªã女æ§ã«æ¯ãã3.25ïœ4.0åé«ããªããšã®å ±åãããããŸããéèè¡æ çã®ãªã¹ã¯ã¯çµå£é¿åŠè¬æçšéå§ã®æåã®1幎éã«ãããŠæãé«ããªããšã®å ±åããã(æŽã«.第ïŒç« äœçšéçµå£é¿åŠè¬(OC)ãšã¯ïŒäžè¬çæå¹æ§åã³å®å šæ§ïŒãåç § ã¯é¿åŠã®ããã«åŠæ¹ããããã®ã§ãããã®äœ¿çšã«ããããäºé²ããããæ²»çããããããã®ã§ã¯ãªã 35æ³ä»¥äžã§1æ¥15æ¬ä»¥äžã®å«ç è äžèšã®å 倩æ§ããã³åŸå€©æ§è¡æ æ§çŽ å ä¿æè ã«ã¯è©²åœããªãããå«ç ã軜床ã®è¥æºãéèç€ãè¡æ¶²çæ€æ»ãªã©ã§è¡æ çã®Â .éè路確ä¿åŸã«è¡ã£ãç·æ¥äžéšæ¶å管å èŠé¡æ€æ»ã®é£éåçãå¥ã«ç€ºãã ïŒé£éåçã§ã¯ãé£éäžéšãé£éèæ¥åéšãã6ææ¹åãžæ¡åŒµãèè¡ããéèãèªããã ãã®éèããåŽåºæ§åºè¡ãåããŠãããéèã¯ç€ç¶ã§ã¯ãªããè²èª¿ãçœè²ã§ããïŒ.
-> éèç€ããŠã³ããŒãã«ã€ããŠ
å€åœã§ã®å€§èŠæš¡åžè²©åŸèª¿æ»ã«ããã2幎以äžã®è¿œè·¡èª¿æ»ã®çµæãæ¬å€ã®éèè¡æ çã®çºçŸçã¯10,000婊人幎åœãã7.2件ã§ãããéèè¡æ çã®ãªã¹ã¯ã¯é¡è¬(ã¬ããã«ã²ã¹ãã¬ã«çãå«æããçµå£é¿åŠå€)ãšåçã§ããããšãå ±åãããŠããã.ãã«ã飲ãã§ããå Žåã¿ãã³ã¯åºæ¬çã«ãã¡ã§ãããïŒé»åã¿ãã³ããã¡ãªã®ã§ããããïŒã¢ã€ã³ã¹ãªã©ã§ã¯ãªãããã³ãã³ãã¿ãŒã«ã0ã®ãã®ã§ããæåèªäœãéãã®ã§å€§äžå€«ã§ã¯ãšæãã®ã§ãããå¥ã®ãšããã§é»åã¿ãã³ã§ãè¡æ çãå¿çæ¢.ã¯ããæçšããŠãã女æ§ã¯ïŒ¯ïŒ£ãæçšããŠããªã女æ§ãšæ¯èŒãããšéèè¡æ å¡æ ææžïŒã1988幎以éã®ç±³åœçµå£é¿åŠè¬æ·»ä»ææžã¬ã€ãã³ã¹2)ã§ã¯ãåŠåš åã«ïŒ¯ïŒ£ãæçšã æ¥æ¬æ¯æ§ä¿è·å»åäŒã«ãŠå 倩ç°åžžã®èª¿æ»ããããæµç£é²æ¢ã®ããã«åŠåš äžã«ãã æçšçµäºåŸã®çµç£å©ŠäžŠã³ã«æªçµç£å©Šã®1幎åŸã®åŠåš çã¯81ïœ90ïŒ ã§Â .æ¬è³æã¯ãäœçšéçµå£é¿åŠè¬ïŒä»¥äžãOCããšããïŒã®æçšã«äŒŽãå¯äœçšçã«ãã çšè ã«èªèãããããã«ãOCãåŠæ¹ããå»åž«ãæçšè ã«æäŸããæ å ±çããŸãšãã éèç€. 0.2. ç®èããçæ. 0.2ïœ0.6. äœéå¢å . 0.8ïœ2.2. æ¶ååš. ãããŸãã. 0.2 åå®®äœçã®æ»äº¡çãOCã®äœ¿çšã«ãã£ãŠäœäžã7)ãããããã®å¹æã¯5幎åŸãèªãããã䜿çš.è¡æ¶²ã®åæ»ïŒ é·æè¥åºãè¥æºããã£è¡æ§å¿äžå šã»æ ¢æ§èºæ§å¿ãªã©ã®å¿èºçŸæ£ãå šèº«éº»é ãäžè¢éº»çºãäžè¢ã®ãã¹å 垯åºå®ãäžè¢éèç€ã«ããŒãã«æ€æ»ãæ²»çã«ããæ€æ»åŸã®ãããäžå®éãšç©¿åºéšäœã®å§è¿«ãåŠåš ãªã©.第2ç« çµå£é¿åŠè¬(oc)ã®åŠæ¹ã®æé èæãªéèç€ã æçšéå§åŸæ©æã«å¯äœçšã®çºçãç¥ãããã«ååãªå蚺ãšãä¿å¥æå°ãå¿ èŠã«å¿ããå 蚺ãå«ãã身äœç蚺å¯ãæœè¡ãã¹ãã§ããã.粟玢éèç€ãšèšºæãã挢æ¹è¬ãã ã©65ãåŠæ¹ãããŸãããäžã¶æããã飲ã¿ç¶ããŠãŸãããããªããŸããå·ŠçŸäžžã®çã¿ãäžè ¹éšã®ã®çã¿è °ã®çã¿ãçŸåšã®çç¶ã§ãã.èŠ çŽïŒ2014 幎 6 æïŒäžè¢éèç€æ²»çã«é«åšæ³¢ïŒã©ãžãªæ³¢ïŒã«ããçŒçŒè¡ïŒradiofre- quency ablation 6ïŒçµå£é¿åŠè¬ãããã¯ãã«ã¢ã³å€ãæçšããŠã. ãæ£è . 7ïŒé節ãªå¿Â .çè·åŠçã®åœè©Šå¯Ÿçã»å®ç¿ã»å°±æŽ»ã«é¢ããããŠããŠã®ããšãªããªã¯ã«ãŒãã°ã«ãŒãã®ç·åæ å ±ãµã€ããããŒã¹ãã«çè·åŠçããçè·åž«åœå®¶è©Šéšå¯Ÿçãå®ç¿ãä¹ãåãããŠããŠãªã©ãå¿ããçè·åŠçããµããŒãïŒ.
-> éèç€æ²»ç
éèç€ãšã¯ã¢ã®å·£ç¶éèç€ã¯ãåŠåš äžã®å¥³æ§ã50æ³ãéãã女æ§ã«å€ãèŠãããçç¶ã§ããè¡æ¶²åŸªç°ã«åé¡ãããããã«çºçããããšãå€ããã»ãšãã©ã®å Žåãäžè¢ã®éèãšæ¯çŽ°è¡ç®¡ãæ¡åŒµããããšã§çããŸãã.5幎åã®æ±åé¢æ±å€§å°éãä»åã®çæ¬å°éã§ã倧ããªè¢«å®³ãå ±ããããŠãããšã³ãããŒã¯ã©ã¹çå矀ã倧å°éã®åŸã¯ãçã延ã³ãæ¹ã ã®äžã«ããèºå¡æ çã§äº¡ããªãæ¹ãå°ãªããããŸãããäžè¢ãªã©ã§ã§ããè¡æ ïŒè¡ã®ãããŸãïŒãèºã«è©°ãŸã£ãŠãéçã®å Žåã¯æ»ã«è³ãç æ°ã§ãã.çµå£é¿åŠè¬äœ¿çš pvtã®10幎çåçã¯38-60%ã§æ»äº¡åå ã®å€§åã¯åºç€çŸæ£ã«ãããã®. éèç€ããã®åºè¡ã«ããæ»äº¡ã¯è硬å€ãããå°ãªã, 5%çšåºŠ. åºè¡äºé²ç®çã®Î²é»å®³è¬, å èŠé¡çéèç€.éïŒæ ¢æ§éèäžå šçïŒäžè¢éèç€ïŒè¡ç®¡å¥åœ¢ïŒæ·±éšéèè¡æ çïŒå€å·åŸããã³çè «æåºåŸã®éé¢çµ ãç®çãäžå€§éèãã£ã«ã¿ãŒã¯èŽæ»çãªèºå¡æ äºé²ã®ããçŸåšã§ã¯åºãæ®åããŠãããã®ã®ïŒDVT ãå¢å . ãããããšãããã®äž ã¯ã«ãã¡ãªã³ã«å ãéãã¿ãã³ K é»å®³çµå£æååºè¬ stentã4äŸïŒself expandable stentã35äŸã«ç眮ããïŒãçµ.çµå£é¿åŠè¬ïŒããããã²ã«ããããè±èª: combined oral contraceptive pill (COCP)ãoral ãã«ã¯è¡æ ãèµ·ãããªã¹ã¯ã3 - 5ååŒãäžãããšãããã€ã®ãªã¹ã§10幎éã«104人ãè¡æ ã«ããã2013幎6æã«æçšãã20æ³ä»£ã®å¥³æ§ãé èå éèæŽè¡æ çã§æ»äº¡ããã ã€ãŒãºã¯æçµå°é£çãšåå®®å èçã®æ²»çã®ããã«ããããœãããã§ã³ãã¬ãããã .軜床ïŒã®ãšã³ãããŒã¯ã©ã¹çå矀ã®è¡æ ã¯èªç¶ã«ãªããªããŸããïŒçµ¶å¯Ÿç é¢è¡ã£ãã»ããããã§ããïŒ è¡æ ã®å€§ããã«ãããŸãããšã³ãããŒã¯ã©ã¹çå矀ããšéèè¡æ å¡æ çïŒèºè¡æ å¡æ çãæ·±éšéèè¡æ çïŒã«ã€ããŠæŠç¥ã.éèè¡æ å¡æ çã«ã€ããŠ. å»çåŸäºè ã®æ¹ã ãžãéèè¡æ å¡æ çãã«é¢ããæ å ±ãã å±ãããŸãã éèè¡æ å¡æ çãšã¯ïŒ éèè¡æ å¡æ çã®åºæ¬æŠå¿µãšçºççãªã©ã解説ã ãŸãã DVTã®äºé²æ³ã«ã€ããŠ. æ·±éšéèè¡æ çã®äºé²æ³ã«ã€ããŠã玹ä»ããŸãã Related.2019幎7æ4æ¥ ã¬ã€ãã©ã€ã³ã¯ïŒç¢ºå®ã«ææãå®æœããããã®åç §ã§ããããã¥ã¢ã«ãšã¯éã£ãŠ ããªãã£ãäžè¢éèç€ã®æ¥åž°ãæè¡ãšãããããªããšãæ®éã«ãªãïŒæ¥æ¬å šåœæŽ¥ã 3幎ã®ç¡åçºç87ïŒ ãšè¯å¥œã§35ïŒïŒRFAã«æ¯ã¹ãŠè¡åŸã®çŒçãå°ãªãããšã è¬å€ã«é¢ããŠã¯çµå£é¿åŠè¬ïŒãã«ïŒïŒãã«ã¢ã³å€ïŒã¹ããã€ãè¬ã代衚çã§ããïŒÂ .ãç«åŠãè³éèè¡æ çã¯çºççã幎é100äžäººããã5人çšåºŠã§, å šè³åäžã®1%çšåºŠãå ããçŸæ£ã§ãã. çŽ8å²ã50æ³ä»¥äžã§, ç·æ§ãã女æ§ã«å€ãããšãç¥ãããŠãã. ç·å¥³æ¯ã«é¢ããŠã¯åŠåš , ç£è€¥, çµå£é¿åŠè¬ã®é¢äžã圱é¿ããŠãããšæããã. ãç å (è¡š1)ãã1.
Éèç€ã®ããã®35幎åŸã®çµå£é¿åŠè¬:
Rating: 755 / 645
Overall: 81 Rates